Dominant effects of RET receptor misexpression and ligand-independent RET signaling on ureteric bud development.

During kidney development, factors from the metanephric mesenchyme induce the growth and repeated branching of the ureteric bud, which gives rise to the collecting duct system and also induces nephrogenesis. One signaling pathway known to be required for this process includes the receptor tyrosine kinase RET and co-receptor GFR(&agr;)-1, which are expressed in the ureteric bud, and the secreted ligand GDNF produced in the mesenchyme. To examine the role of RET signaling in ureteric bud morphogenesis, we produced transgenic mice in which the pattern of RET expression was altered, or in which a ligand-independent form of RET kinase was expressed. The Hoxb7 promoter was used to express RET throughout the ureteric bud branches, in contrast to its normal expression only at the bud tips. This caused a variable inhibition of ureteric bud growth and branching reminiscent of, but less severe than, the RET knockout phenotype. Manipulation of the level of GDNF, in vitro or in vivo, suggested that this defect was due to insufficient rather than excessive RET signaling. We propose that RET receptors expressed ectopically on ureteric bud trunk cells sequester GDNF, reducing its availability to the normal target cells at the bud tips. When crossed to RET knockout mice, the Hoxb7/RET transgene, which encoded the RET9 isoform, supported normal kidney development in some RET-/- animals, indicating that the other major isoform, RET51, is not required in this organ. Expression of a Hoxb7/RET-PTC2 transgene, encoding a ligand-independent form of RET kinase, caused the development of abnormal nodules, outside the kidney or at its periphery, containing branched epithelial tubules apparently formed by deregulated growth of the ureteric bud. This suggests that RET signaling is not only necessary but is sufficient to induce ureteric bud growth, and that the orderly, centripetal growth of the bud tips is controlled by the spatially and temporally regulated expression of GDNF and RET.

[1]  K. Hagino-Yamagishi,et al.  [Oncogene]. , 2019, Gan to kagaku ryoho. Cancer & chemotherapy.

[2]  J. Milbrandt,et al.  GFRα1-Deficient Mice Have Deficits in the Enteric Nervous System and Kidneys , 1998, Neuron.

[3]  A. McMahon,et al.  GDNF induces branching and increased cell proliferation in the ureter of the mouse. , 1997, Developmental biology.

[4]  H. Sariola,et al.  The tip-top branching ureter. , 1997, Current opinion in cell biology.

[5]  M. Saarma,et al.  Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. , 1997, Development.

[6]  S. Vainio,et al.  Inductive Tissue Interactions, Cell Signaling, and the Control of Kidney Organogenesis , 1997, Cell.

[7]  N. Asai,et al.  Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations. , 1997, Biochemical and biophysical research communications.

[8]  A. Palotie,et al.  Cloning, mRNA Distribution and Chromosomal Localisation of the Gene for Glial Cell Line-Derived Neurotrophic Factor Receptor β, a Homologue to GDNFR-α , 1997 .

[9]  J. Milbrandt,et al.  TrnR2, a Novel Receptor That Mediates Neurturin and GDNF Signaling through Ret , 1997, Neuron.

[10]  S. Aizawa,et al.  Defects of urogenital development in mice lacking Emx2. , 1997, Development.

[11]  G. Dressler,et al.  The molecular basis of embryonic kidney development , 1997, Mechanisms of Development.

[12]  T. Pawson,et al.  RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2 , 1997, Oncogene.

[13]  M. Borrello,et al.  Identification of Shc docking site on Ret tyrosine kinase , 1997, Oncogene.

[14]  G. Lenoir,et al.  Distinct biological properties of two RET isoforms activated by MEN 2A and MEN 2B mutations , 1997, Oncogene.

[15]  C. Worby,et al.  Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Worby,et al.  Glial Cell Line-derived Neurotrophic Factor Signals through the RET Receptor and Activates Mitogen-activated Protein Kinase* , 1996, The Journal of Biological Chemistry.

[17]  B. Wehrle-Haller,et al.  Ectopic c-kit expression affects the fate of melanocyte precursors in Patch mutant embryos. , 1996, Developmental biology.

[18]  N. Asai,et al.  A Mutation at Tyrosine 1062 in MEN2A-Ret and MEN2B-Ret Impairs Their Transforming Activity and Association with Shc Adaptor Proteins* , 1996, The Journal of Biological Chemistry.

[19]  Jonas Frisén,et al.  Renal agenesis and the absence of enteric neurons in mice lacking GDNF , 1996, Nature.

[20]  I. Fariñas,et al.  Renal and neuronal abnormalities in mice lacking GDNF , 1996, Nature.

[21]  Mart Saarma,et al.  Defects in enteric innervation and kidney development in mice lacking GDNF , 1996, Nature.

[22]  A. Buj-Bello,et al.  Characterization of a multicomponent receptor for GDNF , 1996, Nature.

[23]  J. Louis,et al.  GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNF , 1996, Cell.

[24]  E. Arenas,et al.  Functional receptor for GDNF encoded by the c-ret proto-oncogene , 1996, Nature.

[25]  B. Ponder,et al.  GDNF signalling through the Ret receptor tyrosine kinase , 1996, Nature.

[26]  V. D’Agati,et al.  Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development. , 1996, Development.

[27]  H. Sariola,et al.  Localization of Glial Cell Line‐derived Neurotrophic Factor (GDNF) mRNA in Embryonic Rat by In Situ Hybridization , 1996, The European journal of neuroscience.

[28]  R. A. Decker,et al.  Oncogenic RET Receptors Display Different Autophosphorylation Sites and Substrate Binding Specificities (*) , 1996, The Journal of Biological Chemistry.

[29]  N. Asai,et al.  Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation. , 1996, Oncogene.

[30]  Susan S. Taylor,et al.  Tyrosines outside the Kinase Core and Dimerization Are Required for the Mitogenic Activity of RET/ptc2 (*) , 1995, The Journal of Biological Chemistry.

[31]  A. Zelenetz,et al.  The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  N. Asai,et al.  Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations , 1995, Molecular and cellular biology.

[33]  F. Costantini,et al.  Isolation and characterization of a chicken homolog of the c-ret proto-oncogene. , 1995, Oncogene.

[34]  al. et,et al.  Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B , 1995, Science.

[35]  T. Tsuzuki,et al.  Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. , 1995, Oncogene.

[36]  Jonathan B. L. Bard,et al.  Towards a genetic basis for kidney development , 1994, Mechanisms of Development.

[37]  A Greco,et al.  The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. , 1994, Oncogene.

[38]  Frank Costantini,et al.  Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret , 1994, Nature.

[39]  F. Costantini,et al.  Expression of the c-ret proto-oncogene during mouse embryogenesis. , 1993, Development.

[40]  A. Zelenetz,et al.  W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. , 1993, Development.

[41]  J. Lile,et al.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.

[42]  R. Vogels,et al.  Proximal cis-acting elements cooperate to set Hoxb-7 (Hox-2.3) expression boundaries in transgenic mice. , 1993, Development.

[43]  N. Asai,et al.  cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily. , 1993, Oncogene.

[44]  C. Carcano,et al.  Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A , 1993, Molecular and cellular biology.

[45]  V. D’Agati,et al.  Lectin characterization of cystogenesis in the SBM transgenic model of polycystic kidney disease. , 1992, Journal of the American Society of Nephrology : JASN.

[46]  C Kress,et al.  Hox-2.3 upstream sequences mediate lacZ expression in intermediate mesoderm derivatives of transgenic mice. , 1990, Development.

[47]  H. Hiai,et al.  Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence. , 1989, Oncogene.

[48]  T. Iwamoto,et al.  Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. , 1988, Oncogene.

[49]  G. Cooper,et al.  ret transforming gene encodes a fusion protein homologous to tyrosine kinases , 1987, Molecular and cellular biology.

[50]  L. Saxén.  Failure to demonstrate tubule induction in a heterologous mesenchyme. , 1970, Developmental biology.

[51]  R. Erickson.  Inductive interactions in the development of the mouse metanephros. , 1968 .

[52]  C. Grobstein.  Inductive interaction in the development of the mouse metanephros , 1955 .

[53]  C. Grobstein.  Inductive epitheliomesenchymal interaction in cultured organ rudiments of the mouse. , 1953, Science.

[54]  A. Palotie,et al.  Cloning, mRNA distribution and chromosomal localisation of the gene for glial cell line-derived neurotrophic factor receptor beta, a homologue to GDNFR-alpha. , 1997, Human molecular genetics.

[55]  K. Robertson,et al.  The GDNF-RET signalling partnership. , 1997, Trends in genetics : TIG.

[56]  岩下寿秀.  Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation(MEN2A及びMEN2B型変異を有するRet蛋白の活性化に必須なチロシン残基の同定) , 1997 .

[57]  M. Bucan,et al.  Long-range genomic rearrangements upstream of Kit dysregulate the developmental pattern of Kit expression in W57 and Wbanded mice and interfere with distinct steps in melanocyte development. , 1997, Development.

[58]  F. Costantini,et al.  Expression of the cret proto-oncogene during mouse embryogenesis , 1996 .

[59]  H. Hellmich,et al.  Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions , 1996, Mechanisms of Development.

[60]  D. Wilkinson.  Wholemount in situ hybridization of vertebrate embryos , 1992 .

[61]  T. Sugimura,et al.  Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. , 1990, Oncogene.

[62]  L. Saxén.  Organogenesis of the kidney , 1987 .